GSK plc (GSK) Shareholders & Insider Trades
GSK shareholders at a glance
The largest holder of GSK stock is Fidelity Management & Research Co. LLC, with 232.2 million shares (5.74% of the company), worth about $5.84 billion as of September 25, 2026. The 10 largest holders together own 22.3%.
In Q2 2026, 1,090 institutional holdings reports listed 347.0 million shares worth $18.20 billion, down 7.2% in shares from Q1 2026.
Insiders reported 130 transactions in the last two years: no sales and no purchases. The newest one on file is from August 24, 2026 (Martinez-Davis (Maya), --).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through August 24, 2026.
GSK plc
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest GSK shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Fidelity Management & Research Co. LLC | 232.2 million | 5.74% | $5.8B |
| Vanguard Capital Management LLC | 117.7 million | 2.91% | $3.0B |
| BlackRock Investment Management (UK) Ltd. | 98.9 million | 2.44% | $2.5B |
| Dodge & Cox | 88.8 million | 2.19% | $2.2B |
| BlackRock Advisors (UK) Ltd. | 69.2 million | 1.71% | $1.7B |
| Schroder Investment Management Ltd. | 66.0 million | 1.63% | $1.7B |
| Norges Bank Investment Management | 63.1 million | 1.56% | $1.6B |
| Wellington Management Co. LLP | 62.2 million | 1.54% | $1.6B |
| Geode Capital Management LLC | 52.6 million | 1.30% | $1.3B |
| Vanguard Asset Management Ltd. | 51.2 million | 1.27% | $1.3B |
As of September 25, 2026.
GSK institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,090 | 347.0 million | $18.2B |
| Q1 2026 | 1,072 | 374.0 million | $20.7B |
| Q4 2025 | 1,030 | 398.0 million | $19.5B |
| Q3 2025 | 935 | 388.0 million | $16.8B |
| Q2 2025 | 935 | 386.0 million | $14.8B |
| Q1 2025 | 899 | 365.0 million | $14.1B |
| Q4 2024 | 893 | 341.0 million | $11.5B |
| Q3 2024 | 943 | 309.0 million | $12.6B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
GSK insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Martinez-Davis (Maya) | Aug 24, 2026 | -- | Bought at price 51.78 per share. | $466 |
| Martinez-Davis (Maya) | Aug 21, 2026 | -- | Sold at price 52.15 per share. | $2.3M |
| Martinez-Davis (Maya) | Aug 14, 2026 | -- | Bought at price 49.52 per share. | $4,110 |
| Barron (Hal V) | Aug 14, 2026 | -- | Bought at price 49.52 per share. | $112,905 |
| Barron (Hal V) | Aug 14, 2026 | -- | Bought at price 49.52 per share. | $3,614 |
| Martinez-Davis (Maya) | Aug 7, 2026 | -- | Bought at price 52.96 per share. | $476 |
| Martinez-Davis (Maya) | Jul 14, 2026 | -- | Bought at price 51.67 per share. | $16,586 |
| Ramakrishnan (Shobie) | Jul 14, 2026 | -- | Bought at price 51.67 per share. | $34,102 |
| Lee (Jeannie) | Jul 10, 2026 | -- | Bought at price 52.74 per share. | $896 |
| Martinez-Davis (Maya) | Jul 10, 2026 | -- | Bought at price 52.47 per share. | $8,342 |
| Sikka (Vishal Ph.D.) | Jul 10, 2026 | -- | Bought at price 52.74 per share. | $5,748 |
| Barron (Hal V) | Jul 10, 2026 | -- | Bought at price 52.74 per share. | $1,476 |
Newest 12 of 130 insider transactions in the last two years.
Questions and answers
Who owns the most GSK stock?
Fidelity Management & Research Co. LLC, with 5.74% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (2.91%) and BlackRock Investment Management (UK) Ltd. (2.44%).
How many institutions own GSK stock?
1,090 institutional holdings reports listed GSK shares in Q2 2026, 347.0 million shares in all worth $18.20 billion.
Are GSK insiders buying or selling the stock?
In the last two years insiders reported no sales and no purchases (130 transactions in all); the newest on file is from August 24, 2026.
